People
Edmund Power is counsel in King & Spalding’s Special Matters and Investigations practice.
Edmund is an experienced trial attorney and investigator who represents companies and individuals in government and corporate investigations and related criminal and regulatory matters. He has significant experience defending clients in matters involving federal and state False Claims Acts, the Foreign Corrupt Practices Act, and in investigations brought by the U.S. Department of Justice and Securities and Exchange Commission.
From 2003 to 2010, Edmund was a federal prosecutor, first with the Criminal Enforcement Section of the U.S. Department of Justice’s Tax Division and then as an Assistant U.S. Attorney with the United States Attorney's Office for the Eastern District of Virginia.
In these roles, Edmund led investigations that resulted in the convictions of more than 100 individuals and entities for felony offenses. He also successfully conducted 11 jury trials, including those of a former SEC enforcement attorney for conspiracy to commit securities fraud, of a mortgage broker and CPA for mortgage fraud, and of a Northern Virginia crime family for racketeering.
Before beginning his legal career, Edmund served as an infantry officer in the United States Marine Corps and attained the rank of Captain.
J.D., Washington and Lee University School of Law, magna cum laude
B.A., College of the Holy Cross, cum laude
District of Columbia
U.S. District Court for the Eastern District of Virginia
Virginia
Represented a publicly traded medical device manufacturer during a jury trial and acquittal on federal criminal charges relating to “off-label” marketing.
Represented an international shipping company in resolving False Claims Act qui tam litigation with the federal government and 17 state attorneys general.
Represented the former CEO of a regenerative medicine company in providing testimony to the SEC.
See more
March 3, 2020
Foreign Influence Lessons From Research Org FCA Deal
February 25, 2020
DOJ Announces FCA Settlement with NIH-Funded Institute Related to Disclosure of Foreign Influence in Research
October 16, 2019
DOJ Issues Guidance for Evaluating a Business Organization's Inability to Pay a Criminal Fine or Penalty
Represented a publicly traded medical device manufacturer during a jury trial and acquittal on federal criminal charges relating to “off-label” marketing.
Represented an international shipping company in resolving False Claims Act qui tam litigation with the federal government and 17 state attorneys general.
Represented the former CEO of a regenerative medicine company in providing testimony to the SEC.
See more
March 3, 2020
Foreign Influence Lessons From Research Org FCA Deal
February 25, 2020
DOJ Announces FCA Settlement with NIH-Funded Institute Related to Disclosure of Foreign Influence in Research
October 16, 2019
DOJ Issues Guidance for Evaluating a Business Organization's Inability to Pay a Criminal Fine or Penalty
J.D., Washington and Lee University School of Law, magna cum laude
B.A., College of the Holy Cross, cum laude
District of Columbia
U.S. District Court for the Eastern District of Virginia
Virginia